As of Jun 02
| +0.96 / +3.95%|
The 14 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 53.50, with a high estimate of 72.00 and a low estimate of 33.00. The median estimate represents a +112.64% increase from the last price of 25.16.
The current consensus among 15 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.